Css LLC Xeris Biopharma Holdings, Inc. Transaction History

Css LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.04 - $3.22 $36,972 - $58,359	18,124 New	18,124 $40,000
Q4 2022 Feb 14, 2023	SELL	$1.14 - $1.65 $16,917 - $24,486	-14,840 Reduced 37.26%	24,991 $33,000
Q3 2022 Nov 14, 2022	SELL	$1.37 - $1.93 $37,679 - $53,080	-27,503 Reduced 40.85%	39,831 $62,000
Q1 2022 May 16, 2022	SELL	$2.0 - $2.87 $5,000 - $7,175	-2,500 Reduced 3.58%	67,334 $172,000
Q4 2021 Feb 14, 2022	BUY	$1.8 - $2.93 $125,701 - $204,613	69,834 New	69,834 $205,000

142

59.9M

148K

45.7K

Ticker XERS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,956,992
Market Cap $432M
Description
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.